The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Adma Biologics Inc (NASDAQ: ADMA) closed at $17.70 in the last session, down -4.99% from day before closing price of $18.63. In other words, the price has decreased by -$4.99 from its previous closing price. On the day, 2.94 million shares were traded. ADMA stock price reached its highest trading level at $18.97 during the session, while it also had its lowest trading level at $17.315.
Ratios:
We take a closer look at ADMA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 48.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.70. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4184103168 and an Enterprise Value of 4208784384. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 64.06, and their Forward P/E ratio for the next fiscal year is 24.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.93 while its Price-to-Book (P/B) ratio in mrq is 18.04. Its current Enterprise Value per Revenue stands at 10.994 whereas that against EBITDA is 33.431.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $4.06. The 50-Day Moving Average of the stock is -6.21%, while the 200-Day Moving Average is calculated to be 31.41%.
Shares Statistics:
According to the various share statistics, ADMA traded on average about 4.69M shares per day over the past 3-months and 2140240 shares per day over the past 10 days. A total of 236.38M shares are outstanding, with a floating share count of 228.48M. Insiders hold about 3.35% of the company’s shares, while institutions hold 88.43% stake in the company. Shares short for ADMA as of 1732838400 were 12906077 with a Short Ratio of 2.75, compared to 1730332800 on 15198480. Therefore, it implies a Short% of Shares Outstanding of 12906077 and a Short% of Float of 5.6199998.
